KAREN A DAWES Insider Trading $RGEN REPLIGEN CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KAREN A DAWES.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KAREN A DAWES. KAREN A DAWES is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in REPLIGEN CORP ($RGEN) and Director in DEPOMED INC ($DMI) and Director in Vaccitech plc ($VACC).

KAREN A DAWES in REPLIGEN CORP

Trading Symbol: RGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KAREN A DAWES: Director
Holdings: 115,734 shares
Current Value: $3,384,062
Latest Transaction: May 13 2021
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of KAREN A DAWES in REPLIGEN CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, DMI, PDLI, RGEN, VACC

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 13 2021	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.22	15,000	48,300	0
May 13 2021	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	176.85	285	50,402	115,449	115.7 K to 115.4 K (-0.25 %)
May 13 2021	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.22	15,000	48,300	115,734	100.7 K to 115.7 K (+14.89 %)
Jun 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	116.56	2,568	299,326	100,734	103.3 K to 100.7 K (-2.49 %)
Jun 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	115.76	8,217	951,200	103,302	111.5 K to 103.3 K (-7.37 %)
Jun 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	114.49	5,243	600,271	111,519	116.8 K to 111.5 K (-4.49 %)
Jun 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	113.58	2,677	304,054	116,762	119.4 K to 116.8 K (-2.24 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	140.29	182	25,533	119,439	119.6 K to 119.4 K (-0.15 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	139.40	282	39,311	119,621	119.9 K to 119.6 K (-0.24 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	136.98	43	5,890	119,903	119.9 K to 119.9 K (-0.04 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	135.91	10	1,359	119,946	120 K to 119.9 K (-0.01 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	140.29	182	25,533	119,439	119.6 K to 119.4 K (-0.15 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	139.40	282	39,311	119,621	119.9 K to 119.6 K (-0.24 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	136.98	43	5,890	119,903	119.9 K to 119.9 K (-0.04 %)
May 21 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	135.91	10	1,359	119,946	120 K to 119.9 K (-0.01 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	128.18	1,761	225,725	1,761
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	142.45	80	11,396	119,956	120 K to 120 K (-0.07 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	141.45	77	10,892	120,036	120.1 K to 120 K (-0.06 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	140.62	180	25,312	120,113	120.3 K to 120.1 K (-0.15 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	139.32	122	16,997	120,293	120.4 K to 120.3 K (-0.10 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	138.60	269	37,283	120,415	120.7 K to 120.4 K (-0.22 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	136.92	160	21,907	120,684	120.8 K to 120.7 K (-0.13 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	135.76	712	96,661	120,844	121.6 K to 120.8 K (-0.59 %)
May 19 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	722	0	121,556	120.8 K to 121.6 K (+0.60 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.30	11,800	38,940	0
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.30	8,200	27,060	11,800
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.30	11,800	38,940	120,834	109 K to 120.8 K (+10.82 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	104.42	8,998	939,571	109,034	118 K to 109 K (-7.62 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	104.98	3,202	336,146	118,032	121.2 K to 118 K (-2.64 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.30	8,200	27,060	121,234	113 K to 121.2 K (+7.25 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	97.52	1,849	180,314	113,034	114.9 K to 113 K (-1.61 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	99.12	906	89,803	114,883	115.8 K to 114.9 K (-0.78 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	99.85	945	94,358	115,789	116.7 K to 115.8 K (-0.81 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	101.06	300	30,318	116,734	117 K to 116.7 K (-0.26 %)
Jun 19 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	4.96	20,000	99,200	0
Jun 19 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	77.35	1,295	100,168	117,034	118.3 K to 117 K (-1.09 %)
Jun 19 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	4.96	20,000	99,200	118,329	98.3 K to 118.3 K (+20.34 %)
May 17 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	67.71	2,953	199,948	2,953
May 17 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	1,292	0	98,329	97 K to 98.3 K (+1.33 %)
May 17 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	42.07	4,626	194,616	4,626
May 17 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	2,080	0	97,037	95 K to 97 K (+2.19 %)
May 15 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	5.08	20,000	101,600	0
May 15 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	41.80	20,000	835,936	94,957	115 K to 95 K (-17.40 %)
May 15 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	5.08	20,000	101,600	114,957	95 K to 115 K (+21.06 %)
May 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	38.76	3,459	134,071	3,459
May 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	1,714	0	94,957	93.2 K to 95 K (+1.84 %)
Mar 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	4.29	20,000	85,800	0
Mar 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	34.12	2,521	86,017	93,243	95.8 K to 93.2 K (-2.63 %)
Mar 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	4.29	20,000	85,800	95,764	75.8 K to 95.8 K (+26.40 %)
Jul 15 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	20,000	0	75,764	55.8 K to 75.8 K (+35.87 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.10	15,000	46,500	0
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.10	15,000	46,500	0
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Payment of Exercise	F	23.46	1,982	46,498	55,764	57.7 K to 55.8 K (-3.43 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Payment of Exercise	F	23.46	1,982	46,498	55,764	57.7 K to 55.8 K (-3.43 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.10	15,000	46,500	57,746	42.7 K to 57.7 K (+35.09 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.10	15,000	46,500	57,746	42.7 K to 57.7 K (+35.09 %)
May 13 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	26.12	4,783	124,932	4,783
May 13 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	2,505	0	42,746	40.2 K to 42.7 K (+6.22 %)
Nov 12 2015	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	26.70	1,000	26,700	40,241	39.2 K to 40.2 K (+2.55 %)
May 26 2015	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	41.19	2,929	120,646	2,929
May 26 2015	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	1,498	0	39,241	37.7 K to 39.2 K (+3.97 %)

Page: 1